{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pulmonary-embolism/background-information/pathophysiology/","result":{"pageContext":{"chapter":{"id":"ad38abd5-7668-59b3-828a-9edd427dbdd5","slug":"pathophysiology","fullItemName":"Pathophysiology","depth":2,"htmlHeader":"<!-- begin field 6430725a-c90b-4469-bb01-98ed25be52df --><h2>What is the pathophysiology?</h2><!-- end field 6430725a-c90b-4469-bb01-98ed25be52df -->","summary":"","htmlStringContent":"<!-- begin item af48410e-4c5c-4a49-a1e4-4412e8355168 --><!-- begin field 266e401e-e7b8-4675-95ed-2ad38778a3cd --><ul><li><strong>Pulmonary embolism (PE) occurs when one or more emboli, usually arising from a thrombus (blood clot) formed in the veins, are lodged in and obstruct the pulmonary arteries.</strong><ul><li>When a PE is present, the lung tissue is ventilated but not perfused, resulting in an intra-pulmonary dead space and impaired gas exchange [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Camm and Bunce, 2005</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Tarbox, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>].<ul><li>​​The area of lung that is no longer perfused by the pulmonary artery may infarct, but often does not do so because oxygen continues to be supplied by the bronchial circulation and the airways.</li><li>This leads to a reduction in the cross-sectional area of the pulmonary arterial bed, which results in an elevation of pulmonary arterial pressure and a reduction in cardiac output.</li><li>After several hours, alveolar collapse occurs, which worsens hypoxaemia.</li><li>Large or multiple emboli can abruptly increase pulmonary arterial pressure to a level of afterload that cannot be matched by the right ventricle. Sudden death may occur, or the person may present with hypotension or syncope, which might progress to shock or death due to acute right ventricular failure.</li></ul></li><li>The deep veins of the lower limbs are most commonly affected, but thrombosis may affect other sites, including the upper limbs, cerebral veins, and splanchnic veins [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">SIGN, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">National Clinical Guideline Centre, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Di Nisio, 2016</a>]. </li></ul></li><li><strong>Non-thrombotic sources of emboli include </strong><strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Camm and Bunce, 2005</a>]</strong><strong> </strong><strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pulmonary-embolism/references/\">Konstantinides, 2014</a>]</strong><strong>:</strong><ul><li>Tumours — most commonly prostate and breast cancers.</li><li>Fat — from long-bone fractures.</li><li>Amniotic fluid in pregnant women.</li><li>Sepsis — for example, tricuspid valve endocarditis in people who inject illicit drugs intravenously or have infected indwelling catheters or pacemaker wires; people with peripheral septic thrombophlebitis; or recipients of transplanted organs.</li><li>Foreign bodies — during intravenous drug use or from broken catheters, guide wires, vena cava filters, embolization coils, and endovascular stent components.</li><li>Air — admitted during surgery or from other communication between the environment and the venous system.</li></ul></li></ul><!-- end field 266e401e-e7b8-4675-95ed-2ad38778a3cd --><!-- end item af48410e-4c5c-4a49-a1e4-4412e8355168 -->","topic":{"id":"322088c5-226e-5f2b-9fd2-2e2c0678abc1","topicId":"6b233aab-5318-4abb-96fa-1877e917ef2c","topicName":"Pulmonary embolism","slug":"pulmonary-embolism","lastRevised":"Last revised in October 2020","chapters":[{"id":"7d60ce89-0a3c-5336-a5d4-755eb5bfb2cd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"99df9a07-7867-5283-b7c8-4589c8f6e029","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b4da2d8a-f835-512f-b218-660b7fc61806","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c60f44ed-a5f4-566e-8718-a289b4d4e969","slug":"changes","fullItemName":"Changes"},{"id":"42a750f4-f134-55a8-a654-9c23ac2a3bfd","slug":"update","fullItemName":"Update"}]},{"id":"b8001d19-4cf2-5db4-b8b5-f082fbff4fbd","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"52656989-9cf4-597c-8118-0fadcb887b21","slug":"goals","fullItemName":"Goals"},{"id":"cdd140ec-bd30-59e9-9777-c921159ea664","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c32413cc-9382-5aaa-b03b-95ed29a1b360","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c1a308a6-aa46-578f-98f1-ed7872474fb4","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"1629cec2-329a-5273-a313-15a0783d5b22","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"d4860e1f-9b8b-5f49-bdb5-fb068af327ab","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"9e6802a1-b9c3-5fa9-b632-ef9712c1724b","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"588bb6e5-794e-52df-9953-d91254204285","slug":"definition","fullItemName":"Definition"},{"id":"e2fbb90b-8419-52d9-bfd2-a9eab621be3b","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad38abd5-7668-59b3-828a-9edd427dbdd5","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"9b45f610-d957-50a3-9e85-019832acd145","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e279dc8-2394-5073-8866-952291c0eee6","slug":"complications","fullItemName":"Complications"},{"id":"8be5980d-145d-5d9c-b255-f057579ce868","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"c07c0850-0c27-58a8-96a8-96051968c076","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"1db70c8e-a80c-587a-8e5e-5adf28878587","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"a71fc8ea-c1d7-5be5-a888-41b834fdca93","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"f18a5246-939d-51ce-adb5-f6538871345a","fullItemName":"Management","slug":"management","subChapters":[{"id":"42f102a2-ceab-531f-880e-4075895d9c12","slug":"suspected-pulmonary-embolism","fullItemName":"Scenario: Suspected pulmonary embolism"},{"id":"cd66b55b-908e-56dc-811f-db55be20b710","slug":"confirmed-pulmonary-embolism","fullItemName":"Scenario: Confirmed pulmonary embolism"}]},{"id":"6ae8a494-48a2-5d60-b0f8-39dd5e02489b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"8b812684-b06c-50e2-86d7-f012b792c674","slug":"parenteral-anticoagulants","fullItemName":"Parenteral anticoagulants"},{"id":"f367e7b5-6b1b-5f42-9d57-a8edab35855f","slug":"oral-anticoagulants","fullItemName":"Oral anticoagulants"}]},{"id":"c1bef62c-2c5a-5588-af53-1a0b4b26d3e3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3941fd8f-10fb-53d4-8dc1-3835ad3ca3e3","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"26fc4bf9-2995-5109-9f1e-3ba9ad3dd2dd","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"f1b2f1f8-81e2-5a3c-b454-2f63f66f6235","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"83fd7f66-6953-54a6-b55f-8d2858a82e97","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"bd9e363f-a674-594d-8bb9-8779d385e06a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"20c76427-9b00-5da0-bd68-6486385780f2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96a22dd0-587f-5051-8263-acea49ba216b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"9e6802a1-b9c3-5fa9-b632-ef9712c1724b","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}